We are looking for a highly motivated, dynamic and creative PhD student to work in the field of plasma medicine to investigate its effects on biomaterials (essentially polymers, namely hydrogels), for cancer and regenerative medicine applications. The ultimate goal is to gain fundamental understanding on the effects of plasma-treated hydrogels on cancer and healthy cells and tissues to implement new strategies for local and minimally invasive cancer therapy. If selected, the candidate will work in a multidisciplinary research group focused on the search for potential anti-cancer treatments in human osteosarcoma, specifically the use of Cold Plasmas at atmospheric pressure on biomaterials, cell lines and primary cells, within an ERC project. This position is part of the Starting Grant “APACHE” of the European Research Council. The selected candidate will occupy a full-time place in the plasma medicine research group, led by Dr. Cristina Canal, in the Biomaterials, Biomechanics and Tissue Engineering Research Group ofthe Technical University of Catalonia at EEBE (Campus Diagonal Besòs), Barcelona (https://ercapache.upc.edu/en ). You will be working in a vibrant interdisciplinary research environment involving plasma physics, biomaterials science and cell biology. You will have access to state-of-the-art experimental facilities, will have travel allowance. You will be expected to deliver top quality research. REQUIREMENTSThe successful candidate will hold a master degree in biomedical engineering, tissue engineering, chemistry, biology and other related areas. Previous exposure to plasma medicine, biomaterials or tissue engineering is highly desirable. However, willingness and motivation to expand your expertise by reaching out to other disciplines is required. You are expected to be proficient in English, and have skills in teamwork and communication skills. The evaluation of the candidate will be based on previous studies, credentials, research experience, exposure to relevant disciplines and proficiency in English. Beside skype interviews, it is possible to arrange on site visits […]
The MITEF Spain Jury has reached this decision considering their business model, technology, market potential and evolution, and the team itself. They have developed a technology that is capable of sequencing RNA, from a small blood sample, and associating the expression of genes in more than 320 metabolic pathways that act as biomarkers of the parameters of the individual’s body, analyzing all those variations that are out of the ordinary to improve and prevent health problems. This project was born as a result of the doctoral thesis, defended at the UPC, of ​​the researcher Emma Roca, a biochemist and elite ultra-distance runner. Roca wanted to analyze the impact of high intensity sport on the runners of an ultra-Trail together with Dr. Jose Manuel Soria, principal investigator of the Genomics of Complex Diseases Research Group of the IIB Sant Pau – Fundació Institut de Recerca Hospital de Sant Pau – Centre CERCA and Dr. Alexandre Perera, physicist, expert in Artificial Intelligence and director of the CREB|UPC, in charge of developing the algorithms that allow the expression of metabolic pathways to be automatically evaluated. Finally, within the framework of the Collider program, in the 2019 edition, Dr. Teresa Tarragó, CEO of the project, and Pol Cervera, director of operations, joined in to give the business perspective and face the market. Congratulations to the whole Exheus Team! Awesome work!